IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children, Single Centre Observational Study
NCT05596656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2022-10-28
Summary
an interviewer-administrated questionnaire was designed to take history of allergy in diabetic child come to outpatient clinic fulfilling inclusion criteria and used to collect data. Skin prick testing was performed to all diabetic children with history of allergy. Laboratory assessment of Serum Total IgE, IL5 and eosinophils%.
Conditions
- Diabetic Children
Interventions
- DIAGNOSTIC_TEST
-
skin prick test
Skin prick testing was performed to all diabetic child with history of allergy. The recommended method of prick testing includes the appropriate use of specific allergen extracts, positive and negative controls, interpretation of the tests after 15 - 20 minutes of application, with a positive result defined as a wheal ≥3 mm diameter more than negative control for detection of specific IgE to one or more of common aeroallergens. The location of each allergen was marked with a pen on the volar aspect of forearm to properly identify test results, at least 2 cm from the wrist and the antecubital fossae. The distance between two skin prick tests should be appropriate to avoid false-positive reactions due to direct contamination of a nearby test. A drop of each test solution should be placed on the skin in identical order for each subject tested and immediately pricked with a single-head metal lancet.
Sponsors & Collaborators
-
Mansoura University Children Hospital
lead OTHER
Principal Investigators
-
Engy Osman, MD · assistant Professor, Pediatrics Department, Faculty of Medicine, Mansoura University, Egypt.
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2019-01-01
- Completion
- 2019-12-25
Countries
- Egypt
Study Locations
More Related Trials
-
Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin
NCT05768191 ·Status: COMPLETED ·Phase: PHASE4
-
Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
NCT03091673 ·Status: COMPLETED ·Phase: PHASE3
-
A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes
NCT03066284 ·Status: UNKNOWN
-
Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)
NCT04756011 ·Status: COMPLETED
-
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564 ·Status: RECRUITING ·Phase: NA
-
Effects of Ramadan Fasting on Type 1 Diabetic Children
NCT07096804 ·Status: NOT_YET_RECRUITING
-
Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
NCT01840358 ·Status: UNKNOWN ·Phase: NA
-
Determinants of Glycaemic Control in Children With Type 1 Diabetes
NCT06325111 ·Status: RECRUITING
-
Low-carbohydrate Diet in Children with Type 1 Diabetes
NCT05078658 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
NCT04992312 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
NCT00357890 ·Status: COMPLETED ·Phase: NA
-
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Resistance in Type I Diabetes in Pediatric Care
NCT00946426 ·Status: WITHDRAWN
-
Prevention of Skin Problems With Diabetes Devices in Pediatric Patients
NCT04258904 ·Status: COMPLETED ·Phase: NA
-
Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt
NCT04531111 ·Status: UNKNOWN
-
Prevalence of Nocturnal Hypoglycemia in Children on a Type 1 Diabetes (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS)
NCT00542334 ·Status: COMPLETED
-
Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
NCT01525784 ·Status: UNKNOWN
-
Evaluation of an Early Screener to Identify Long-term Problems With Regard to Metabolic Control and Treatment Adherence Among Children and Adolescents With Type 1 Diabetes
NCT03642483 ·Status: COMPLETED
-
Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
NCT04640064 ·Status: UNKNOWN
-
Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus
NCT03111433 ·Status: COMPLETED ·Phase: PHASE2
-
Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes
NCT00595569 ·Status: COMPLETED
-
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
NCT01997411 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Risk Factors of Metabolic Control in Children and Adolescents With Type 1 Diabetes
NCT03642470 ·Status: COMPLETED
-
Monocyte Soluble Activation Markers sCD14 and sCD163 in Children With Type 1 Diabetes Mellitus
NCT05347836 ·Status: UNKNOWN